Breast Carcinoma Clinical Trials in Kansas City, Kansas
3 recruitingKansas City, Kansas
Showing 1–3 of 3 trials
Recruiting
Phase 2
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Breast CarcinomaBreast Atypical Hyperplasia
National Cancer Institute (NCI)80 enrolled4 locationsNCT05941520
Recruiting
Phase 2
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Breast CarcinomaBreast Atypical Ductal HyperplasiaBreast Atypical Lobular Hyperplasia
National Cancer Institute (NCI)200 enrolled11 locationsNCT06184750
Recruiting
Phase 2
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Breast CarcinomaBreast Atypical Hyperplasia
National Cancer Institute (NCI)66 enrolled3 locationsNCT06195306